ReviewBiomarker research2021
TOX as a potential target for immunotherapy in lymphocytic malignancies.
Chaofeng Liang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this papertrialcites it
ReviewBiomarker research2021
Chaofeng Liang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.